Tag: ADP101

Alladapt Harmony Study

Alladapt’s 15-Allergen OIT Candidate Ready to Begin Phase 1/2 Study

ADP101 is intended to treat patients with an allergy to one or more of peanut, almond, hazelnut, cashew, pistachio, pecan, walnut, milk, egg, cod, salmon, shrimp, wheat, soy, and sesame.
Harmony Study

Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...

The study is still seeking participants 4-55 years of age.
Clinical Trial

Broad Spectrum OIT Candidate for Multiple Food Allergies Begins Phase 1/2...

The Harmony Study plans to enroll patients across 20 sites in the United States.
Alladapt

Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...

Company is developing therapy to target a number of food allergies simultaneously.